Citadel Advisors LLC lowered its position in shares of National HealthCare Co. (NYSEMKT:NHC) by 23.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,611 shares of the company’s stock after selling 4,900 shares during the quarter. Citadel Advisors LLC owned about 0.10% of National HealthCare worth $1,095,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Cigna Investments Inc. New acquired a new stake in shares of National HealthCare during the 2nd quarter worth approximately $242,000. Prudential Financial Inc. raised its position in shares of National HealthCare by 13.9% during the 2nd quarter. Prudential Financial Inc. now owns 37,866 shares of the company’s stock worth $2,656,000 after purchasing an additional 4,610 shares during the period. Citigroup Inc. raised its position in shares of National HealthCare by 78.1% during the 2nd quarter. Citigroup Inc. now owns 12,966 shares of the company’s stock worth $909,000 after purchasing an additional 5,686 shares during the period. Bowling Portfolio Management LLC acquired a new stake in shares of National HealthCare during the 2nd quarter worth approximately $870,000. Finally, Russell Investments Group Ltd. raised its position in shares of National HealthCare by 1.6% during the 2nd quarter. Russell Investments Group Ltd. now owns 56,013 shares of the company’s stock worth $3,929,000 after purchasing an additional 904 shares during the period.
In related news, SVP Jeffrey Russell Smith sold 1,848 shares of the company’s stock in a transaction on Thursday, September 28th. The shares were sold at an average price of $62.78, for a total value of $116,017.44. Following the completion of the transaction, the senior vice president now directly owns 3,111 shares of the company’s stock, valued at approximately $195,308.58. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
National HealthCare Co. (NYSEMKT:NHC) traded up 0.10% during mid-day trading on Friday, reaching $63.10. The company had a trading volume of 30,080 shares. National HealthCare Co. has a 52-week low of $57.73 and a 52-week high of $78.99. The stock has a market capitalization of $958.80 million, a price-to-earnings ratio of 19.84 and a beta of 0.91. The company’s 50 day moving average is $62.61 and its 200 day moving average is $67.71.
National HealthCare (NYSEMKT:NHC) last posted its quarterly earnings data on Friday, August 4th. The company reported $0.70 earnings per share for the quarter. National HealthCare had a net margin of 4.41% and a return on equity of 6.26%. The firm had revenue of $239.46 million during the quarter. Equities analysts predict that National HealthCare Co. will post $2.54 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, December 1st. Investors of record on Friday, September 29th will be paid a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 3.04%. The ex-dividend date is Thursday, September 28th. National HealthCare’s payout ratio is presently 52.94%.
National HealthCare announced that its Board of Directors has initiated a share buyback plan on Wednesday, August 9th that permits the company to repurchase $25.00 million in outstanding shares. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its shares are undervalued.
ILLEGAL ACTIVITY WARNING: “National HealthCare Co. (NYSEMKT:NHC) Shares Sold by Citadel Advisors LLC” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2017/10/14/national-healthcare-co-nhc-stake-decreased-by-citadel-advisors-llc.html.
A number of analysts have recently weighed in on NHC shares. BidaskClub cut National HealthCare from a “sell” rating to a “strong sell” rating in a research report on Saturday, July 8th. ValuEngine cut National HealthCare from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd.
National HealthCare Profile
National HealthCare Corporation (NHC) is engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The Company is engaged in the post-acute healthcare industry segment. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer’s care, senior living services, and home healthcare services.
Receive News & Ratings for National HealthCare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare Co. and related companies with MarketBeat.com's FREE daily email newsletter.